The University of Colorado Healthcare Innovation Fund, which includes Aurora-based UCHealth and Children’s Hospital Colorado, participated in the oversubscribed series B round for Foresight Diagnostics, which is developing ultrasensitive cancer treatment tests. Foresite Capital led the financing, which also included Stanford (Calif.) University.
“I’ve been extremely impressed by the achievements that Foresight has made towards redefining cancer treatment and the drug development process through precision cancer monitoring,” said Uplaksh Kumar, Ph.D., venture partner at Foresite Capital, in an April 27 news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
